Sue Bell became one of the first Alzheimer's patients in the U.S. to receive the drug now marketed as Leqembi. Her husband ...

A new biomarker test can detect early-stage tau protein clumping up to a decade before it appears on brain scans, improving ...

The past decade has seen a dramatic increase in the technology that allows the detection of minute amounts of disease-related analytes in biofluids. This is ...

The technology – called Antibody Transport Vehicle (ATV): Amyloid beta – can be used to help amyloid-targeting drugs cross the blood brain barrier (BBB) more effectively, say the partners.

When people have Alzheimer’s disease, their brains slowly accumulate abnormal clumps of two proteins: amyloid and tau. At ...

Lecanemab has given us more years together. That’s not ‘minute’ nor ‘minimal’ to me,” writes one reader in STAT’s letters to ...

Phosphorylated tau 217 better detected Alzheimer’s disease pathology across a range of neurodegenerative syndromes compared ...

Attribution (BY): Credit must be given to the creator. Amyloid formation is involved in widespread health conditions such as Alzheimer’s disease, Parkinson’s disease, and type-2 diabetes. Amyloid ...

High levels of “hidden” fat known as visceral fat may put you at higher risk for Alzheimer’s disease up to two decades before ...

Advanced treatment at Loyola University Medical Center is offering remission from a rare blood cancer. Thanks to Loyola’s ...

But the direct-to-consumer ad didn't come from Palo Alto-based Bridge Bio (Nasdaq: BBIO); instead it was produced by Pfizer ...